{"id":3988,"date":"2021-10-12T23:19:33","date_gmt":"2021-10-12T23:19:33","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=3988"},"modified":"2023-08-29T17:51:29","modified_gmt":"2023-08-29T17:51:29","slug":"invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=3988","title":{"rendered":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528"},"content":{"rendered":"<p>Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002<\/p>\n<p>\u4eca\u5e746\u6708\uff0cInvion\u4e0eRMW Cho\u96c6\u56e2\u7b7e\u7f72\u5408\u4f5c\u5f00\u53d1\u534f\u8bae\uff0c\u8fdb\u4e00\u6b65\u5f00\u53d1Invion\u7528\u4e8e\u6cbb\u7597\u52a8\u8109\u7ca5\u6837\u786c\u5316\u548c\u611f\u67d3\u6027\u75be\u75c5\u7684Photosoft\u6280\u672f\u3002<\/p>\n<p>\u4f5c\u4e3a\u6b64\u6b21\u4ea4\u6613\u7684\u4e00\u90e8\u5206\uff0cInvion\u901a\u8fc7\u914d\u552e\u7b79\u96c6\u4e86450\u4e07\u7f8e\u5143\uff0c\u5e76\u5c06\u4e00\u6b21\u6027\u5411RMW\u652f\u4ed8225\u4e07\u7f8e\u5143\u7684\u5f00\u53d1\u8d39\u7528\u3002Invion\u5c06\u62e5\u6709\u6cbb\u7597\u8fd9\u4e9b\u75be\u75c5\u7684\u6280\u672f\u5728\u4e9a\u592a\u5730\u533a(\u4e0d\u5305\u62ec\u5927\u4e2d\u534e\u533a)\u7684\u72ec\u5bb6\u7ecf\u9500\u6743\u3002<\/p>\n<h2>\u5bf9\u66ff\u4ee3\u7597\u6cd5\u7684\u5927\u91cf\u9700\u6c42<\/h2>\n<p>\u6839\u636eInvion\u7684\u8bf4\u6cd5\uff0c\u5728\u6cbb\u7597\u611f\u67d3\u6027\u75be\u75c5\u548c\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\uff0c\u975e\u5e38\u9700\u8981\u6709\u6548\u7684\u66ff\u4ee3\u7597\u6cd5\u3002<\/p>\n<p>\u52a8\u8109\u7ca5\u6837\u786c\u5316\u662f\u5fc3\u8840\u7ba1\u75be\u75c5\u589e\u52a0\u7684\u4e3b\u8981\u539f\u56e0\u3002\u5b83\u4f1a\u5bfc\u81f4\u6591\u5757\u5728\u52a8\u8109\u5185\u5f62\u6210\u3002<\/p>\n<p>\u5fc3\u8840\u7ba1\u75be\u75c5\u662f\u5168\u7403\u6700\u5927\u7684\u6b7b\u4ea1\u539f\u56e0\uff0cInvion\u4f30\u8ba1\uff0c\u52302027\u5e74\uff0c\u6cbb\u7597\u52a8\u8109\u7ca5\u6837\u786c\u5316\u7684\u5e02\u573a\u5c06\u8fbe\u5230566\u4ebf\u7f8e\u5143\u3002<\/p>\n<p>\u4e0e\u6b64\u540c\u65f6\uff0c\u5168\u7403\u5927\u6d41\u884c\u4e5f\u4fc3\u4f7f\u4eba\u4eec\u5173\u6ce8\u4e8e\u5f00\u53d1\u9002\u5f53\u7684\u4f20\u67d3\u75c5\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>\u4ec5COVID-19\u4e00\u9879\u5c31\u4ea7\u751f\u4e86\u524d\u6240\u672a\u6709\u7684\u7ecf\u6d4e\u5f71\u54cd\u2014\u20142020\u5e74\uff0c\u4e16\u754c\u635f\u5931\u8d85\u8fc720\u4e07\u4ebf\u7f8e\u5143\uff0c\u5251\u6865\u5927\u5b66\u9884\u6d4b\uff0c\u6700\u574f\u60c5\u51b5\u4e0b\uff0c\u52302025\u5e74\u5c06\u9ad8\u8fbe82\u4e07\u4ebf\u7f8e\u5143\u3002<\/p>\n<h2>\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u6280\u672f<\/h2>\n<p>Invion\u7684Photosoft\u6280\u672f\u662f\u4e00\u79cd\u6539\u8fdb\u7684\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u3002<\/p>\n<p>\u5b83\u7684\u5de5\u4f5c\u539f\u7406\u662f\u4f7f\u7528\u65e0\u6bd2\u5149\u654f\u5242INV043\uff0c\u8be5\u5149\u654f\u5242\u88ab\u53ef\u89c1\u5149\u6fc0\u6d3b\uff0c\u4ea7\u751f\u7ec6\u80de\u6bd2\u6027\u6d3b\u6027\u6c27\uff0c\u53ef\u4ee5\u6740\u6b7b\u6076\u6027\u548c\u5f02\u5e38\u7ec6\u80de(\u5305\u62ec\u7ec6\u83cc\u548c\u75c5\u6bd2)\uff0c\u5e76\u5173\u95ed\u80bf\u7624\u3002<\/p>\n<p>\u8fd9\u79cd\u6280\u672f\u5728\u505a\u5230\u8fd9\u4e00\u70b9\u7684\u540c\u65f6\u4e5f\u4f1a\u523a\u6fc0\u514d\u75ab\u7cfb\u7edf\u3002<\/p>\n<p>\u8fd9\u4e0e\u653e\u7597\u548c\u5316\u7597\u76f8\u53cd\uff0c\u653e\u7597\u548c\u5316\u7597\u6291\u5236\u764c\u75c7\u7684\u514d\u75ab\u7cfb\u7edf\u3002\u5b83\u5177\u6709\u9ad8\u5ea6\u7684\u7279\u5f02\u6027\u548c\u9488\u5bf9\u6027\uff0c\u51cf\u5c11\u4e86\u8fd9\u4e9b\u6cbb\u7597\u5e26\u6765\u7684\u526f\u4f5c\u7528\u3002<\/p>\n<p>\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u534f\u4f1a\u6279\u51c6\u4e86\u4e00\u4e9b\u764c\u75c7\u548c\u75be\u75c5\u7684\u65e9\u671f\u5149\u52a8\u529b\u7597\u6cd5\uff0c\u5c3d\u7ba1\u5b83\u4eec\u6709\u5c40\u9650\u6027\uff0cInvion\u5e0c\u671b\u7528\u5176Photosoft\u6280\u672f\u6765\u514b\u670d\u3002<\/p>\n<p>\u5982\u679c\u5b83\u80fd\u5728\u611f\u67d3\u6027\u75be\u75c5\u548c\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u53d6\u5f97\u7c7b\u4f3c\u4e8e\u764c\u75c7\u7684\u4ee4\u4eba\u632f\u594b\u7684\u7ed3\u679c\uff0cInvion\u76f8\u4fe1\uff0c\u5b83\u5c06\u5f7b\u5e95\u6539\u53d8\u8fd9\u4e9b\u4e25\u91cd\u75be\u75c5\u7684\u6cbb\u7597\u65b9\u5f0f\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002 \u4eca\u5e746\u6708\uff0cInvion\u4e0eRMW Cho\u96c6\u56e2\u7b7e\u7f72\u5408\u4f5c\u5f00\u53d1\u534f\u8bae\uff0c\u8fdb\u4e00\u6b65\u5f00\u53d1Invion\u7528\u4e8e\u6cbb\u7597\u52a8\u8109\u7ca5\u6837\u786c\u5316\u548c\u611f\u67d3\u6027\u75be\u75c5\u7684Photosoft\u6280\u672f\u3002 \u4f5c\u4e3a\u6b64\u6b21\u4ea4\u6613\u7684\u4e00\u90e8\u5206\uff0cInvion\u901a\u8fc7\u914d\u552e\u7b79\u96c6\u4e86450\u4e07\u7f8e\u5143\uff0c\u5e76\u5c06\u4e00\u6b21\u6027\u5411RMW\u652f\u4ed8225\u4e07\u7f8e\u5143\u7684\u5f00\u53d1\u8d39\u7528\u3002Invion\u5c06\u62e5\u6709\u6cbb\u7597\u8fd9\u4e9b\u75be\u75c5\u7684\u6280\u672f\u5728\u4e9a\u592a\u5730\u533a(\u4e0d\u5305\u62ec\u5927\u4e2d\u534e\u533a)\u7684\u72ec\u5bb6\u7ecf\u9500\u6743\u3002 \u5bf9\u66ff\u4ee3\u7597\u6cd5\u7684\u5927\u91cf\u9700\u6c42 \u6839\u636eInvion\u7684\u8bf4\u6cd5\uff0c\u5728\u6cbb\u7597\u611f\u67d3\u6027\u75be\u75c5\u548c\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\uff0c\u975e\u5e38\u9700\u8981\u6709\u6548\u7684\u66ff\u4ee3\u7597\u6cd5\u3002 \u52a8\u8109\u7ca5\u6837\u786c\u5316\u662f\u5fc3\u8840\u7ba1\u75be\u75c5\u589e\u52a0\u7684\u4e3b\u8981\u539f\u56e0\u3002\u5b83\u4f1a\u5bfc\u81f4\u6591\u5757\u5728\u52a8\u8109\u5185\u5f62\u6210\u3002 \u5fc3\u8840\u7ba1\u75be\u75c5\u662f\u5168\u7403\u6700\u5927\u7684\u6b7b\u4ea1\u539f\u56e0\uff0cInvion\u4f30\u8ba1\uff0c\u52302027\u5e74\uff0c\u6cbb\u7597\u52a8\u8109\u7ca5\u6837\u786c\u5316\u7684\u5e02\u573a\u5c06\u8fbe\u5230566\u4ebf\u7f8e\u5143\u3002 \u4e0e\u6b64\u540c\u65f6\uff0c\u5168\u7403\u5927\u6d41\u884c\u4e5f\u4fc3\u4f7f\u4eba\u4eec\u5173\u6ce8\u4e8e\u5f00\u53d1\u9002\u5f53\u7684\u4f20\u67d3\u75c5\u6cbb\u7597\u65b9\u6cd5\u3002 \u4ec5COVID-19\u4e00\u9879\u5c31\u4ea7\u751f\u4e86\u524d\u6240\u672a\u6709\u7684\u7ecf\u6d4e\u5f71\u54cd\u2014\u20142020\u5e74\uff0c\u4e16\u754c\u635f\u5931\u8d85\u8fc720\u4e07\u4ebf\u7f8e\u5143\uff0c\u5251\u6865\u5927\u5b66\u9884\u6d4b\uff0c\u6700\u574f\u60c5\u51b5\u4e0b\uff0c\u52302025\u5e74\u5c06\u9ad8\u8fbe82\u4e07\u4ebf\u7f8e\u5143\u3002 \u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u6280\u672f Invion\u7684Photosoft\u6280\u672f\u662f\u4e00\u79cd\u6539\u8fdb\u7684\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u3002 \u5b83\u7684\u5de5\u4f5c\u539f\u7406\u662f\u4f7f\u7528\u65e0\u6bd2\u5149\u654f\u5242INV043\uff0c\u8be5\u5149\u654f\u5242\u88ab\u53ef\u89c1\u5149\u6fc0\u6d3b\uff0c\u4ea7\u751f\u7ec6\u80de\u6bd2\u6027\u6d3b\u6027\u6c27\uff0c\u53ef\u4ee5\u6740\u6b7b\u6076\u6027\u548c\u5f02\u5e38\u7ec6\u80de(\u5305\u62ec\u7ec6\u83cc\u548c\u75c5\u6bd2)\uff0c\u5e76\u5173\u95ed\u80bf\u7624\u3002 \u8fd9\u79cd\u6280\u672f\u5728\u505a\u5230\u8fd9\u4e00\u70b9\u7684\u540c\u65f6\u4e5f\u4f1a\u523a\u6fc0\u514d\u75ab\u7cfb\u7edf\u3002 \u8fd9\u4e0e\u653e\u7597\u548c\u5316\u7597\u76f8\u53cd\uff0c\u653e\u7597\u548c\u5316\u7597\u6291\u5236\u764c\u75c7\u7684\u514d\u75ab\u7cfb\u7edf\u3002\u5b83\u5177\u6709\u9ad8\u5ea6\u7684\u7279\u5f02\u6027\u548c\u9488\u5bf9\u6027\uff0c\u51cf\u5c11\u4e86\u8fd9\u4e9b\u6cbb\u7597\u5e26\u6765\u7684\u526f\u4f5c\u7528\u3002 \u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u534f\u4f1a\u6279\u51c6\u4e86\u4e00\u4e9b\u764c\u75c7\u548c\u75be\u75c5\u7684\u65e9\u671f\u5149\u52a8\u529b\u7597\u6cd5\uff0c\u5c3d\u7ba1\u5b83\u4eec\u6709\u5c40\u9650\u6027\uff0cInvion\u5e0c\u671b\u7528\u5176Photosoft\u6280\u672f\u6765\u514b\u670d\u3002 \u5982\u679c\u5b83\u80fd\u5728\u611f\u67d3\u6027\u75be\u75c5\u548c\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u53d6\u5f97\u7c7b\u4f3c\u4e8e\u764c\u75c7\u7684\u4ee4\u4eba\u632f\u594b\u7684\u7ed3\u679c\uff0cInvion\u76f8\u4fe1\uff0c\u5b83\u5c06\u5f7b\u5e95\u6539\u53d8\u8fd9\u4e9b\u4e25\u91cd\u75be\u75c5\u7684\u6cbb\u7597\u65b9\u5f0f\u3002<\/p>\n","protected":false},"author":3,"featured_media":13469,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[986],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528<\/title>\n<meta name=\"description\" content=\"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528\" \/>\n<meta property=\"og:description\" content=\"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-12T23:19:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:51:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invion-Group-ASX-IVX-applications-next-generation-photodynamic-therapy-infectious-diseases-INV043-bacterial-viral-fungal-parasitic-atherosclerosis-heart.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/\",\"name\":\"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-10-12T23:19:33+00:00\",\"dateModified\":\"2023-08-29T17:51:29+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528","description":"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528","og_description":"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/","og_site_name":"smallcapsCN","article_published_time":"2021-10-12T23:19:33+00:00","article_modified_time":"2023-08-29T17:51:29+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invion-Group-ASX-IVX-applications-next-generation-photodynamic-therapy-infectious-diseases-INV043-bacterial-viral-fungal-parasitic-atherosclerosis-heart.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/","url":"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/","name":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-10-12T23:19:33+00:00","dateModified":"2023-08-29T17:51:29+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Invion Group (ASX: IVX)\u5728\u7814\u53d1\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5INV043\u6cbb\u7597\u764c\u75c7\u7684\u540c\u65f6\uff0c\u4e5f\u5728\u63d0\u9ad8\u8be5\u7597\u6cd5\u5728\u6cbb\u7597\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u3001\u5bc4\u751f\u866b\u75be\u75c5\u548c\u5bfc\u81f4\u5fc3\u810f\u95ee\u9898\u7684\u52a8\u8109\u7ca5\u6837\u786c\u5316\u65b9\u9762\u7684\u6f5c\u529b\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invion-group-eyes-multiple-applications-next-generation-photodynamic-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invion Group\u7740\u773c\u4e8e\u4e0b\u4e00\u4ee3\u5149\u52a8\u529b\u7597\u6cd5\u7684\u591a\u79cd\u5e94\u7528"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3988"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3988"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3988\/revisions"}],"predecessor-version":[{"id":13468,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3988\/revisions\/13468"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/13469"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}